| Filed On | Filing |
|---|---|
| 23 Oct 2026 |
8-K: Other Events
2 October 23, 2026 Legal Notices The information in this slide deck is current as of October 23, 2026, unless otherwise noted, and is qualified in its entirety by reference to MacroGenics’ Annual, Quarterly and Current Reports filed with... |
| 22 Oct 2026 | 144 |
| 07 Oct 2026 |
Form 4: Bonvini Ezio, Sr VP, Research & CSO
Received 8,000 shares by exercise or conversion ($20.8K) |
| 21 Sep 2026 | 144 |
| 03 Sep 2026 | S-8 |
| 03 Sep 2026 |
8-K/A: Financial Statements and Exhibits
Effective as of June 30, 2026, MacroGenics, Inc. (the “Company”) completed the previously announced sale (the “Closing”) of certain assets and liabilities related to its GMP manufacturing operations (the "Purchased Assets"), including it... |
| 20 Aug 2026 |
Form 4: Peters Jeffrey Stuart, Senior VP, GC, and Secretary
Sold 31,105 shares ($129K) |
| 19 Aug 2026 | 144 |
| 18 Aug 2026 |
Form 4: Bonvini Ezio, Sr VP, Research & CSO
Received 40,000 shares by exercise or conversion ($104K) |
| 17 Aug 2026 | 144 |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | 10-Q |
| 13 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 03 Aug 2026 | 144 |
| 03 Aug 2026 | SCHEDULE 13G/A |
| 29 Jul 2026 | SCHEDULE 13G |
| 23 Jul 2026 | 8-K: Other Events |
| 20 Jul 2026 | SCHEDULE 13G/A |
| 13 Jul 2026 | 144 |
| 08 Jul 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
Loading...
